New TB Vaccine Initiatives by South Africa
South Africa prepares for a revolutionary new TB vaccine aimed at preventing tuberculosis in adolescents and adults by 2028.
Funding Gap Threatens HIV and TB Progress
Understanding the consequences of the funding gap on South Africa's health crisis following the withdrawal of crucial US aid.
Global Health Giants Consider Merger Amidst Funding Crunch
Examine the significance of collaboration between the Global Fund and Gavi in responding to the global health financing crisis.
Casual contact drives TB spread more than household exposure
Insights from a KZN study reveal that casual contact drives TB, shifting the focus from close household exposure to community interactions.
HIV programmes: The impact of funding US cuts
US funding cuts to SAs HIV programme threaten to reverse decades of progress, potentially leading to increased infections, hospitalisations, and deaths.
56,000 South Africans succumbed to tuberculosis in 2023
In 2023, tuberculosis was the top infectious disease killer worldwide, with 1.25 million deaths. SA's TB incidence is declining, but fatalities remain high.
Competition Commission and J&J reach TB drug agreement
Following an agreement with the Competition Commission, J&J will not enforce its TB drug patent in 134 countries and will reduce the drug price in South Africa.